Treace Medical Concepts Q3 Adjusted Loss Widens, Revenue Rises; Lowers Annual Revenue Outlook
-- Treace Medical Concepts reported late Thursday a Q3 adjusted loss of $0.28 per diluted share, widening from a loss of $0.22 a year earlier. Three analysts polled by Capital IQ expected a loss of...
Source: marketscreener.com